Hematology & Oncology Doctors in Seneca, PA Accepting Medicare

2 Hematology & Oncology doctors found. Showing 1 - 2

Nava Siegelmann-danieli, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 100 Fairfield Dr, Seneca, PA 16346 Phone: 814-676-7900

Shannon Kristen Penland, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 Fairfield Drive, Upmc Hillman Cancer Center Northwest, Seneca, PA 16346 Phone: 814-676-7900    Fax: 814-676-7887

News Archive

Premion commences cancer treatment with Varian's RapidArc radiotherapy technology

Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.

E-cigarettes attracting youth to use tobacco products, new UC San Francisco study finds

E-cigarettes - thought by some to be responsible for a decline in youth cigarette smoking - are actually attracting a new population of adolescents who might not otherwise have smoked tobacco products, according to a new UC San Francisco study.

NIH-sponsored clinical trials examine safety, acceptability of HIV antiretroviral medicines

Two new clinical trials are examining the safety and acceptability of antiretroviral medicines administered via injection as a means of protecting against HIV infection. The studies are being funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and conducted by the NIAID-funded HIV Prevention Trials Network (HPTN).

Researchers discover mechanisms responsible for chemoresistance in ovarian cancer

The presence of multiple ovarian cancer genomes in an individual patient and the absence or downregulation of the gene LRP1B are associated with the development of chemoresistance in women with the high-grade serous cancer subtype of ovarian cancer whose disease recurs after primary treatment. These study results are published in Cancer Research, a journal of the American Association for Cancer Research.

Women treated with fertility drugs do not have increased breast cancer risk, study shows

Drugs routinely used during fertility treatments to release eggs do not increase the risk of developing breast cancer, new research has shown.

Read more Medical News

› Verified 7 days ago